경피 흡수형 패치 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Transdermal Skin Patches Market size is expected to reach USD 15.02 Billion in 2034 from USD 9.30 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global transdermal skin patches market has grown steadily as healthcare providers seek convenient and controlled drug delivery methods. Transdermal patches deliver medication through the skin directly into the bloodstream, offering consistent dosing and improved patient compliance. These patches are widely used for pain management, hormone therapy, smoking cessation, and other medical treatments.

Several drivers are contributing to the expansion of the transdermal skin patches market. Increasing prevalence of chronic diseases and growing demand for non-invasive treatment options have encouraged the use of transdermal drug delivery systems. Pharmaceutical companies are investing in research to develop new patch formulations that improve drug absorption and therapeutic effectiveness.

Future prospects for the transdermal skin patches market appear promising as advancements in drug delivery technology continue. Innovations in materials and patch design may enable the delivery of a wider range of medications. Growing demand for convenient healthcare solutions and personalized treatment options is expected to support continued growth in this market.

MARKET SEGMENTATION

By Type

• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Other Types

By Application

• Pain Relief
• Smoking Reduction And Cessation Aid
• Cardiovascular Disorders
• Neurological Disorders
• Hormonal Therapy
• Other Applications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Teva Pharmaceutical Industries Ltd, Novartis AG, Teikoku Pharma USA Inc, Viatris Inc, Johnson Johnson, Luye Pharma Group, Purdue Pharma Manufacturing LP, Henan Lingrui Pharmaceutical Co Ltd, Samyang Biopharmaceuticals Corporation, Hisamitsu Pharmaceutical Co Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Single-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Multi-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Smoking Reduction And Cessation Aid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hormonal Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TRANSDERMAL SKIN PATCHES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Teva Pharmaceutical Industries Ltd
  • 9.2.2 Novartis AG
  • 9.2.3 Teikoku Pharma USA Inc
  • 9.2.4 Viatris Inc
  • 9.2.5 Johnson & Johnson
  • 9.2.6 Luye Pharma Group
  • 9.2.7 Purdue Pharma Manufacturing LP
  • 9.2.8 Henan Lingrui Pharmaceutical Co. Ltd
  • 9.2.9 Samyang Biopharmaceuticals Corporation
  • 9.2.10 Hisamitsu Pharmaceutical Co. Inc